Rapid ART: An Essential Strategy to End the HIV Epidemic
Resource updated 03/15/2023
Resource updated 03/15/2023
Resource updated 09/19/2023
Resource updated 08/28/2023
Resource updated 09/19/2023
Blog updated 02/01/2021
Anal dysplasia programs are a growing need as anal dysplasia is an increasing concern in men and women with HIV. This presentation will discuss establishing, implementing, and maintaining an anal dysplasia program in a Ryan White clinic setting. Ideas for future evaluation will also be addressed.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Learn about strategies for improving access to oral healthcare through better integration with primary care. Presenters will share information on the seven components of integration, ranging from risk assessments to data sharing across settings. This session will introduce the components of integration and highlight available resources for integrative care.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
This presentation will review how the Michigan Department of Health and Human Services Chronic Disease Division collaborated with the HIV/STI division and local AIDS service organizations to develop innovative, client-centered tobacco dependence treatment programs to address the high tobacco use rates among people with HIV.
Resource (Conference Presentation) updated 09/14/2023
This session will highlight strategies to coordinate federal, state, and local funding streams to improve viral suppression for clients experiencing unstable housing. This is a panel session, and attendees will have the opportunity to share ideas, best practices, and roadblocks, and ask questions.
Resource (Conference Presentation) updated 09/14/2023
Sound monitoring practices require collaboration across an organization to implement strong financial and program management systems. The Texas Ryan White Part B program and fiscal monitoring units have developed robust processes and tools to share with other Ryan White recipients.
Resource (Conference Presentation) updated 09/14/2023
HRSA/HAB guidance on using RWHAP funds to provide services to eligible individuals in prisons, jails, and other correctional systems allows recipients to determine which RWHAP services to provide and for how long. This session will provide overviews of HAB policy and two recipients' programs serving people who are justice-involved.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023